• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及 2001-2012 年丙型肝炎病毒感染预防和控制进展。

Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012.

出版信息

MMWR Morb Mortal Wkly Rep. 2012 Jul 27;61(29):545-9.

PMID:22832935
Abstract

Worldwide, 130-170 million persons are living with chronic hepatitis C virus (HCV) infection, which, if left untreated, can result in cirrhosis and liver cancer. Egypt has the largest burden of HCV infection in the world, with a 10% prevalence of chronic HCV infection among persons aged 15-59 years. HCV transmission in Egypt is associated primarily with inadequate infection control during medical and dental care procedures. In response, the Egyptian Ministry of Health and Population (MOHP) in 2001 implemented a program to reduce health-care-associated HCV transmission and in 2008 launched a program to provide care and treatment. This report describes the progress of these programs, identifies deficiencies, and recommends enhancements, including the establishment of a comprehensive national viral hepatitis control program. Infection control programs implemented in 2001 at MOHP facilities resulted in improvements in infection control practices and a decrease in the annual incidence of HCV infection among dialysis patients from 28% to 6%. Through June 2012, a total of 23 hepatitis treatment facilities had been established in Egypt, providing care and treatment to nearly 190,000 persons with chronic HCV infection. Despite these programs, Egypt continues to face an ongoing hepatitis C epidemic. A comprehensive plan is needed to prevent and control hepatitis C in Egypt. This plan should address increasing community awareness and education, preventing of HCV infection in health-care settings, ensuring a safe blood supply, establishing surveillance and monitoring to track the effectiveness of control programs, and providing care and treatment.

摘要

全球有 1.3 亿至 1.7 亿人患有慢性丙型肝炎病毒 (HCV) 感染,如果不加以治疗,可能会导致肝硬化和肝癌。埃及是世界上 HCV 感染负担最重的国家,15 至 59 岁人群中慢性 HCV 感染率为 10%。埃及 HCV 的传播主要与医疗和牙科护理程序中感染控制不足有关。为此,埃及卫生和人口部 (MOHP) 于 2001 年实施了一项旨在减少医源性 HCV 传播的计划,并于 2008 年启动了一项提供护理和治疗的计划。本报告介绍了这些计划的进展情况,确定了不足之处,并提出了改进建议,包括建立一个全面的国家病毒性肝炎控制计划。MOHP 设施于 2001 年实施的感染控制计划改善了感染控制措施,并将透析患者 HCV 年感染率从 28%降至 6%。截至 2012 年 6 月,埃及共设立了 23 家肝炎治疗机构,为近 19 万名慢性 HCV 感染者提供护理和治疗。尽管开展了这些计划,埃及仍面临持续的丙型肝炎流行。埃及需要制定一项全面计划来预防和控制丙型肝炎。该计划应包括提高社区意识和教育,在医疗保健环境中预防 HCV 感染,确保安全的血液供应,建立监测和监测系统以跟踪控制计划的效果,并提供护理和治疗。

相似文献

1
Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012.埃及 2001-2012 年丙型肝炎病毒感染预防和控制进展。
MMWR Morb Mortal Wkly Rep. 2012 Jul 27;61(29):545-9.
2
Surveillance for acute viral hepatitis - United States, 2007.2007年美国急性病毒性肝炎监测
MMWR Surveill Summ. 2009 May 22;58(3):1-27.
3
Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients.血液透析患者丙型肝炎病毒感染的流行病学、监测和预防。
Am J Kidney Dis. 2010 Aug;56(2):371-8. doi: 10.1053/j.ajkd.2010.01.025. Epub 2010 Jun 8.
4
Evolution of infection control in Egypt: achievements and challenges.埃及感染控制的演变:成就与挑战。
Am J Infect Control. 2006 May;34(4):193-200. doi: 10.1016/j.ajic.2005.05.028.
5
Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.埃及丙型肝炎病毒的流行感染:过去发病率以及未来发病和死亡情况的估计
J Viral Hepat. 2009 Sep;16(9):650-8. doi: 10.1111/j.1365-2893.2009.01115.x. Epub 2009 Apr 20.
6
National surveillance of dialysis-associated diseases in the United States, 2002.2002年美国透析相关疾病的全国监测
Semin Dial. 2005 Jan-Feb;18(1):52-61. doi: 10.1111/j.1525-139X.2005.18108.x.
7
Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study.预防和治疗干预对埃及丙型肝炎病毒传播的影响(ANRS 1211):一项建模研究。
Lancet Glob Health. 2014 Sep;2(9):e541-e549. doi: 10.1016/S2214-109X(14)70188-3. Epub 2014 Aug 27.
8
Surveillance for acute viral hepatitis--United States, 2006.2006年美国急性病毒性肝炎监测
MMWR Surveill Summ. 2008 Mar 21;57(2):1-24.
9
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.整合多种针对注射吸毒者丙型肝炎预防和护理的项目及政策方法:一种综合方法。
Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20.
10
Incidence of hepatitis c virus seroconversion among hemodialysis patients in the Nile Delta of Egypt: A single-center study.埃及尼罗河三角洲地区血液透析患者丙型肝炎病毒血清学转换的发生率:一项单中心研究。
Saudi J Kidney Dis Transpl. 2017 Jan-Feb;28(1):107-114. doi: 10.4103/1319-2442.198162.

引用本文的文献

1
Genomics in Egypt: Current Status and Future Aspects.埃及的基因组学:现状与未来展望
Front Genet. 2022 May 13;13:797465. doi: 10.3389/fgene.2022.797465. eCollection 2022.
2
Egypt's Ambitious Strategy to Eliminate Hepatitis C Virus: A Case Study.埃及消除丙型肝炎病毒的宏伟战略:案例研究。
Glob Health Sci Pract. 2021 Mar 31;9(1):187-200. doi: 10.9745/GHSP-D-20-00234.
3
Hepatitis C virus infection and risk factors among patients and health-care workers of Ain Shams University hospitals, Cairo, Egypt.埃及开罗艾因夏姆斯大学医院患者和医护人员中的丙型肝炎病毒感染和危险因素。
PLoS One. 2021 Feb 8;16(2):e0246836. doi: 10.1371/journal.pone.0246836. eCollection 2021.
4
Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia.伊朗、埃及和格鲁吉亚丙型肝炎预防、筛查及治疗的比较
J Virus Erad. 2019 Apr 1;5(2):116-121. doi: 10.1016/S2055-6640(20)30053-4.
5
The role of hepatic progenitor cells in predicting response to therapy in Egyptian patients with chronic hepatitis C, genotype 4.肝祖细胞在预测埃及慢性丙型肝炎4型患者治疗反应中的作用
Afr Health Sci. 2019 Mar;19(1):1411-1421. doi: 10.4314/ahs.v19i1.14.
6
Identifying Opportunity for Online Education to Address HIV/HCV Knowledge Gaps in Health Professionals and Students in Egypt.识别在线教育在解决埃及卫生专业人员和学生中 HIV/HCV 知识差距方面的机会。
Ann Glob Health. 2018 Nov 5;84(4):580-583. doi: 10.9204/aogh.2388.
7
Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17.埃及急性乙型和丙型肝炎病毒感染相对风险持续降低的证据,以及甲型肝炎病毒感染负担的增加:2001-2017 年哨点急性病毒性肝炎监测结果比较。
BMC Infect Dis. 2019 Feb 14;19(1):159. doi: 10.1186/s12879-019-3806-9.
8
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.迈向丙型肝炎病毒消除:埃及的经验、成就和局限。
World J Gastroenterol. 2018 Oct 14;24(38):4330-4340. doi: 10.3748/wjg.v24.i38.4330.
9
Assessing the level of knowledge and available sources of information about hepatitis C infection among HCV-infected Egyptians.评估埃及 HCV 感染者对丙型肝炎感染的了解程度和可用信息来源。
BMC Public Health. 2018 Jun 18;18(1):747. doi: 10.1186/s12889-018-5672-6.
10
Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt's hepatocellular cancer epidemic: simulation of alternatives.基于索磷布韦的国家丙型肝炎治疗计划对埃及肝细胞癌流行的预测影响:替代方案模拟
BMJ Glob Health. 2018 Apr 20;3(2):e000572. doi: 10.1136/bmjgh-2017-000572. eCollection 2018.